Results obtained in the LifEscozul™ Protocol in patient Jose Daniel Ibarra.
In this interview, for the LifEscozul Protocol™ (Escozul™, blue scorpion venom, blue scorpion) we spoke today with Mr. José Daniel Ibarra from Argentina.
José Daniel joined the LifEscozul Protocol™ in 2017. He had previously suffered from colorectal cancer with liver metastases, which had been treated with chemotherapy and radiotherapy and operated. Unfortunately after a few months in control check-ups, it was discovered in tomography that the disease had returned and there were metastases in multiple locations.
This interview was conducted by Biologist Ariel Portal for the LifEscozul™ Protocol (Escozul™, blue scorpion venom, blue scorpion venom).
José Daniel was treated with LifEscozul™ (protein active ingredient) with periodic controls and progressive dose increases.
After 8 months of using LifEscozul™ Jose's last examination revealed that the disease had disappeared.
For any questions please write to firstname.lastname@example.org or fill out the form.
The LifEscozul Group™ continues with this interview a cycle of interviews with our oldest patients within the LifEscozul Protocol™ ( Escozul, blue scorpion venom, blue scorpion).
LifEscozul™ is a product with a registered trademark in the USA and Ecuador and in the process of registration in more than 20 countries. It has been developed by Cuban doctors and scientists based on the antitumor active ingredient extracted from blue scorpion venom (Escozul™).